Ajanta Pharma (AJANTPHARM) — Announcement

Ajanta Pharma announced its schedule for analyst and institutional investor meetings on June 17-18, 2026, in Mumbai, confirming discussions will be based solely on previously published information and subject to change due to operational exigencies.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"How does this announcement affect Ajanta Pharma Limited's outlook?" "What did Ajanta Pharma Limited announce on 12 June 2026?" "Is this positive or negative for AJANTPHARM?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 12 June 2026

RACLGEAR RACL Geartech Limited Financial Results RGL Renaissance Global Limited Announcement PRAKASH Prakash Industries Limited Announcement PTL PTL Enterprises Limited Announcement RATNAVEER Ratnaveer Precision Engineering Limited Corporate Action SAATVIKGL Saatvik Green Energy Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.